Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium

Stem Cells

Volumn 15, Issue 2, 1997, Pages 82-93

  Potten, C S ^a   Wilson, J W ^a   Booth, C ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Epithelium; Intestine; Stem cell

Indexed keywords

APOPTOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; DIGESTIVE SYSTEM CANCER; GROWTH REGULATION; HOMEOSTASIS; HUMAN; INTESTINE EPITHELIUM; NONHUMAN; REVIEW; STEM CELL; TUMOR SUPPRESSOR GENE;

EID: 0030895235     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150082     Document Type: Review

References (96)

1. Kumar S, Lavin MF. The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ 1996;3:255-267.
2. Wyllie A. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1990;284:555-556.
3. Oberhammer F, Wilson JW, Dive C et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to, or in the absence of, intemucleosomal fragmentation. EMBO J 1993;12:3679-3684.
4. Gravrieli Y, Sherman Y, Ben-Sasson A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
5. Kaufmann SH, Desnoyers S, Ottaviano Y et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993;53:3976-3985.
6. Potten CS. Structure, function and proliferative organization of the mammalian gut. In: Potten CS, Hendry JH, eds. Radiation and Gut. Amsterdam: Elsevier, 1995:1-31.
7. Potten CS. Extreme sensitivity of some intestinal crypts to X and γ-irradiation. Nature 1977;269:518-521.
8. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 1992;11:179-195.
9. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls, and uncertainties: lessons for and from the crypt. Development 1990;110:1001-1020.
10. Potten CS. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 1990;58:925-973.
11. Hall P, Coates PJ, Ansari B et al. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3565-3577.
12. Shibahara T, Sato N, Waguri S et al. The fate of effete epithelial cells at the villus tip of the human small intestine. Arch Histol Cytol 1995;58:205-219.
13. Potten CS, Allen TD. Ultrastructure of cell loss in intestinal mucosa. J Ultrastruct Res 1977;60:272-277.
14. Polzar B, Zanotti S, Stephan H et al. Distribution of deoxyribonuclease I in rat tissues and its correlation to cellular turnover and apoptosis (programmed cell death). Eur J Cell Biol 1994;64:200-210.
15. Barnard JA, Warwick GJ, Gold LI. Localisation of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology 1993;105:67-73.
16. Probstmeier R, Martini R, Tacke R et al. Expression of the adhesion molecules L1, N-CAM and J1/tenascin during development of the murine small intestine. Differentiation 1990;44:42-55.
17. Probstmeier R, Martini R, Schachner M. Expression of J1 /tenascin in the crypt-villus unit of adult mouse small intestine: implications for its role in epithelial cell shedding. Development 1990;109:313-321.
18. Raff MC, Barnes BA, Burne JF et al. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993;262:695-700.
19. Boudreau N, Sympson CJ, Werb Z et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-893.
20. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three dimensional dermal collagen. PNAS 1994;91:8856-8860.
21. Bates RC, Lincz LF, Burns GF. Involvement of integrins in cell survival. Cancer Metastasis Rev 1995;14:191-203.
22. Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a survival factor. Mol Biol Cell 1993;4:953-961.
23. Frisch SM, Francis H. Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol 1994;124:619-626.
24. Ruoslahti E, Reed JC. Anchorage dependence, integrins and apoptosis. Cell 1994;77:477-478.
25. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1996;270:1203-1207.
26. Hendry JH, Potten CS, Chadwick C. Cell death (apoptosis) in the mouse small intestine after low doses: effects of dose rate, 14.7 MeV neutrons and 600 MeV (maximum energy) neutrons. Int J Radiat Biol 1982;42:611-620.
27. Paulus U, Potten CS, Loeffler M. A model of the control of cellular regeneration in the intestinal crypt after perturbation based solely on local stem cell regulation. Cell Prolif 1992;25:559-578.
28. Ijiri K, Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983;47:175-185.
29. Ijiri K, Potten CS. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 1987;55:113-123.
30. Li YQ, Fan CY, O'Connor PJ et al. Target cells for the cytotoxic effects of carcinogens in the murine small bowel. Carcinogenesis 1992;13:361-368.
31. Potten CS, Li YQ, O'Connor PJ et al. A possible explanation for the differential cancer incidence in the intestine, based on distributions of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 1992;13:2305-2312.
32. Lifshitz S, Schwanz B, Polak-Charon S et al. Disruption of colonie cell-cell interaction induces apoptosis. Gastroenterology 1995;108:498a.
33. Keenan KD, Sharpnack DD, Collins H et al. Morphological evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. Am J Pathol 1986;125:69-80.
34. Shaposhnikov Y, Maheshwari Y, Sykes DE et al. Intestinal cell apoptosis and Bcl-2 expression. Cell Death Differ 1996;3:125-130.
35. Lowe SW, Schmitt EM, Smith SW et al. P53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993;362:847-849.
36. Clarke AR, Purdie CA, Harrison DJ et al. Thymocyte apoptosis induced by p53 dependent and independent pathways. Nature 1993;362:849-852.
37. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
38. Merritt AJ, Potten CS, Kemp CJ et al. The role of p53 in spontaneous and radiation induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Res 1994;54:614-617.
39. Merritt AJ, Potten CS, Watson AJ et al. Differential expression of Bcl-2 in intestinal epithelia: correlation with attenuation of apoptosis in colonie crypts and the incidence of colonie neoplasia. J Cell Sci 1995;108:2261-2271.
40. Lane DP. p53 guardian of the genome. Nature 1992;358:15-16.
41. Mosner J, Deppert W. p53 and mdm2 are expressed independently during cellular proliferation. Oncogene 1994;9:3321-3328.
42. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
43. Wu X, Bayle JH, Olsen D et al. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993;7:1126-1132.
44. Mosner J, Mummenbrauer T, Bauer C et al. Negative feedback regulation of wild type p53 biosynthesis. EMBO J 1995;14:4442-4449.
45. Polyak K, Waldman T, He T-C et al. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996;10:1945-1952.
46. Tanaka N, Ishihara M, Lamphier MS et al. Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature 1996;382:816-818.
47. Hollstein M, Sidransky D, Vogelstein B et al. p53 mutations in human cancers. Science 1991;253:49-53.
48. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-456.
49. Watson AJM, Merritt AJ, Jones LS et al. Evidence for reciprocity of Bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 1996;73:889-895.
50. Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-221.
51. Norimura T, Katsuki M, Nomoto S et al. P53 dependent apoptosis suppresses radiation induced teratogenesis. Nature Medicine 1996;2:577-580.
52. Tsujimoto Y, Finger LR, Yunis J et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984;226:1097-1099.
53. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of Bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-5218.
54. Chen-Levy Z, Nourse J, Cleary ML. The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18). Mol Cell Biol 1989;9:701-710.
55. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalise pre-B cells. Nature 1988;335:440-442.
56. Yin X-M, Oltavi ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with bax. Nature 1994;369:321-323.
57. Boise LH, Gonzalez-Garcia M, Postema CE et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:1-20.
58. Kosopas KM, Yang T, Buchan HL et al. Mcl-1, a gene expressed in programmed myeloid cell differentiation has sequence similarity to Bcl-2. Proc Natl Acad Sci USA 1993;90:3516-3520.
59. Takayama S, Sato T, Krajewski S et al. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 1995;80:279-284.
60. Choi SS, Park I-C, Yun JW et al. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 1996;11:1693-1698.
61. Das R, Reddy EP, Chatterjee D et al. Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma. Oncogene 1996;12:947-951.
62. Gibson L, Holmgreen SP, Huang DCS et al. Bcl-w, a novel member of the Bcl-2 family, promotes cell survival. Oncogene 1996;13:665-675.
63. Oltavi ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerises in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
64. L and Bcl-2, displaces bax and promotes cell death. Cell 1995;80:285-291.
65. Farrow SN, White JHM, Martinou I et al. Cloning of a Bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995;374:731-733.
66. Chittenden T, Harrington EA, O'Conner R et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995;374:733-736.
67. Keifer MC, Brauer MJ, Powers VC et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995;374:736-739.
68. Boyd JM, Gallo GJ, Elangovan B et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995;11:1921-1928.
69. Oltavi ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994;79:189-192.
70. L. Nature 1996;379:554-556.
71. Potten CS, Hendry JH. Clonal regeneration studies. In: Potten CS, Henry JH, eds. Radiation and Gut. Amsterdam: Elsevier, 1995:45-59.
72. Clarke AR, Gledhill S, Hooper ML et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 1994;9:1767-1773.
73. Bracey TS, Miller JC, Preece A et al. γ-irradiation induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene 1995;10:2391-2396.
74. Hooper ML. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 1994;18:13-17.
75. Waldmann T, Lengauer C, Kinzler KW et al. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716.
76. Kitada S, Krajewski S, Miyashita T et al. γ-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 1996;12:187-192.
77. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990;250:1233-1238.
78. Srivastava S, Zou Z, Pirollo K et al. Germ-line transmission of a mutated p53 gene in cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-749.
79. Shapiro L, Fannon AM, Kwong PD et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995;374:327-337.
80. Hermiston ML, Wong MH, Gordon JI. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev 1996;10:985-996.
81. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-324.
82. Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumourigenesis. Nature 1992;359:235-237.
83. 1 to S phase. EMBO J 1995;14:5618-5625.
84. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995;55:2910-2919.
85. Clarke AR, Cummings MC, Harrison DJ. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 1995;11:1913-1920.
86. Narisawa T, Takahashi M, Niwa M et al. Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and antipromotion by the cyclooxygenase inhibitor indomethacin. Jpn J Cancer Res 1987;78:791-798.
87. Earnst DL, Hixson LJ, Alberts DS. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J Cell Biochem Suppl 1992;161:156-166.
88. Rao CV, Simi B, Wynn TT et al. Modulating effect of amount and type of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res 1996;56:532-537.
89. Alberts DS, Hixson L, Ahnen D et al. Do NSAIDs exert the colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl 1995;22:18-23.
90. Gustafson-Svard C, Lilja I, Hallbook O et al. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane-induced colonic tumors in rats. Gut 1996;38:79-84.
91. DuBois RN, Radhika A, Reddy BS et al. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996;110:1259-1262.
92. Rao CV, Rivenson A, Simi B et al. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal anti-inflammatory agent. Cancer Res 1995;55:1464-1472.
93. Yoshimi N, Ino N, Suzui M et al. The mRNA overexpression of inflammatory enzymes, phospholipase A2 and cyclooxygenase, in the large bowel mucosa and neoplasms of F344 rats treated with naturally occurring carcinogen, 1-hydroxyanthraquinone. Cancer Lett 1995;97:75-82.
94. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
95. Takahashi M, Fukutake M, Yokota S et al. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase-2. J Cancer Res Clin Oncol 1996;122:219-222.
96. Nasseri-Sina P, Fawthrop DJ, Wilson JW et al. Cytoprotection by iloprost against paracetamol-induced toxicity in isolated hamster hepatocytes. Br J Pharmacol 1992;105:417-423.